233 related articles for article (PubMed ID: 21710853)
21. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Becx-Bleumink M; Berhe D
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
[TBL] [Abstract][Full Text] [Related]
22. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
Sampaio EP; Malta AM; Sarno EN; Kaplan G
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
[TBL] [Abstract][Full Text] [Related]
23. Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines.
Balagon MF; Cellona RV; Cruz Ed; Burgos JA; Abalos RM; Walsh GP; Saunderson PR; Walsh DS
Am J Trop Med Hyg; 2009 Nov; 81(5):895-9. PubMed ID: 19861628
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years.
Shaw IN; Natrajan MM; Rao GS; Jesudasan K; Christian M; Kavitha M
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):405-9. PubMed ID: 11332283
[TBL] [Abstract][Full Text] [Related]
25. Short-term multidrug therapy in multibacillary leprosy--review of 80 cases in two provinces of China (1983-1988).
Li HY; Yu XL; Zhang MS; Duan CX; Huang WB; Zhang SB; Zhu K; Ma JF
Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):622-7. PubMed ID: 2778368
[TBL] [Abstract][Full Text] [Related]
26. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
[TBL] [Abstract][Full Text] [Related]
27. Relapses in multibacillary leprosy patients: a retrospective cohort of 11 years in Colombia.
Guerrero-Guerrero MI; Muvdi-Arenas S; León-Franco CI
Lepr Rev; 2012 Sep; 83(3):247-60. PubMed ID: 23356026
[TBL] [Abstract][Full Text] [Related]
28. 10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy.
Katoch K; Katoch VM; Natrajan M; Sreevatsa ; Gupta UD; Sharma VD; Shivanavar CT
Vaccine; 2004 Sep; 22(27-28):3649-57. PubMed ID: 15315844
[TBL] [Abstract][Full Text] [Related]
29. Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin.
Katoch K; Katoch VM; Natarajan M; Gupta UD; Sharma VD; Singh HB
Indian J Lepr; 2008; 80(4):331-44. PubMed ID: 20329382
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics and outcome in multibacillary (MB) leprosy patients treated with 12 months WHO MDT-MBR: a retrospective analysis of 730 patients from a leprosy clinic at a tertiary care hospital of Northern India.
Dogra S; Kumaran MS; Narang T; Radotra BD; Kumar B
Lepr Rev; 2013 Mar; 84(1):65-75. PubMed ID: 23741883
[TBL] [Abstract][Full Text] [Related]
31. A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens.
Fajardo TT; Villahermosa L; Pardillo FE; Abalos RM; Burgos J; Dela Cruz E; Gelber RH
Am J Trop Med Hyg; 2009 Aug; 81(2):330-4. PubMed ID: 19635893
[TBL] [Abstract][Full Text] [Related]
32. A young man with livid facial nodules and a loss of eyebrows.
Weberschock T; Göttig S
Lancet Infect Dis; 2013 Mar; 13(3):276. PubMed ID: 23427892
[No Abstract] [Full Text] [Related]
33. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
Balagon M; Saunderson PR; Gelber RH
Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929
[TBL] [Abstract][Full Text] [Related]
34. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):421-35. PubMed ID: 1474281
[TBL] [Abstract][Full Text] [Related]
35. Fixed-duration therapy (FDT) in multibacillary leprosy; efficacy and complications.
Vijayakumaran P; Jesudasan K; Manimozhi N
Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):123-7. PubMed ID: 8690969
[TBL] [Abstract][Full Text] [Related]
36. Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature.
Ozturk Z; Tatliparmak A
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27549245
[TBL] [Abstract][Full Text] [Related]
37. Eye disease in multibacillary leprosy patients at the time of their leprosy diagnosis: findings from the Longitudinal Study of Ocular Leprosy (LOSOL) in India, the Philippines and Ethiopia.
Courtright P; Daniel E; Sundarrao ; Ravanes J; Mengistu F; Belachew M; Celloria RV; Ffytche T
Lepr Rev; 2002 Sep; 73(3):225-38. PubMed ID: 12449887
[TBL] [Abstract][Full Text] [Related]
38. Atypical Hansen's disease presenting as florid verrucous plaques on the lower extremities: a case report.
Yuchua-Guillen A; Dofitas BL
Int J Dermatol; 2012 Jun; 51(6):697-701. PubMed ID: 22607288
[TBL] [Abstract][Full Text] [Related]
39. Experience with multidrug therapy in paucibacillary leprosy.
Bhate RD; Gupta CM; Chattopadhyay SP; Singh IP
Indian J Lepr; 1986; 58(2):244-50. PubMed ID: 3805797
[TBL] [Abstract][Full Text] [Related]
40. Alternate Anti-Leprosy Regimen for Multidrug Therapy Refractory Leprosy: A Retrospective Study from a Tertiary Care Center in North India.
Narang T; Bishnoi A; Dogra S; Saikia UN; Kavita
Am J Trop Med Hyg; 2019 Jan; 100(1):24-30. PubMed ID: 30298809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
